Accessibility Menu
Dr. Martens Plc logo

Dr. Martens Plc(OTC) DOCMF

Market Cap$1.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-82%
5 Year-82%
1 Year-4%
1 Month+9%
$1.06
+3.92%
+0.04Today
Dr. Martens Plc last closing stock price
MetricPriceDate
Last closeUSD 1.062026-07-31
Dr. Martens Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.95%USD 1.012026-07-22
1 month+9.28%USD 0.972026-06-26
3 month+24.71%USD 0.852026-04-29
Year to date+4.26%USD 1.022025-12-29
1 year-3.99%USD 1.102025-07-29
3 year-37.73%USD 1.702023-08-01
5 year-81.65%USD 5.782021-07-29
Since inception-82.12%USD 5.932021-02-04

Dr. Martens Plc Financials at a Glance

Market Cap

$1.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£1.55B

Net Income (TTM)

£28.39M

EPS (TTM)

$0.03

P/E Ratio

32.12

Dividend

$0.03

Beta (Volatility)

0.34 (Low)

Price

$1.06

Volume

5,000

Open

$1.06

Previous Close

$1.06

Daily Range

$1.06 - $1.06

52-Week Range

$0.81 - $1.36

Estimated Earnings Date

Nov 26, 2026

DOCMF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Dr. Martens Plc

Dr. Martens plc is a global enterprise specializing in the complete lifecycle management of its footwear offerings. Established in 1945 and headquartered in London, the company designs, develops, markets, and distributes a diverse range of footwear products under the iconic Dr. Martens brand.

Products and Services
  • Footwear collections including "Originals" and "Fusion"
  • Children's footwear and casual lines
  • Accessories sold exclusively under the Dr. Martens brand
Growth Outlook
  • Recent quarterly revenue reached GBP 444 million, indicating strong market demand
  • Gross profit margin improved to 59% in the latest quarter
  • Expansion into new markets across Europe, the Americas, and Asia-Pacific
Financial Highlights
  • Trailing twelve months (TTM) revenue of GBP 1.5 billion
  • Net income of GBP 33.9 million reported in the latest quarter
  • Dividend yield of 3.28% reflects commitment to shareholder returns
Dr. Martens plc has established itself as a leader in the footwear industry, known for its quality and distinctive style. The company's recent financial performance demonstrates resilience and growth potential, with a notable increase in revenue and profitability. The strong gross profit margin indicates effective cost management and pricing strategies. Furthermore, the commitment to expanding into new markets positions Dr. Martens for continued growth. The dividend yield also highlights the company's dedication to providing value to its shareholders. Overall, Dr. Martens plc presents an intriguing opportunity for potential investors interested in the consumer cyclical sector.
AI Generated • Jul 30, 2026

Industry

Textiles, Apparel and Luxury Goods

Sector

Consumer Discretionary

Employees

2,377

CEO

Ije Nwokorie

Website

www.drmartensplc.com

Headquarters

London, GL NW1 7BY, GB

DOCMF Financials

Key Financial Metrics (TTM)

Gross Margin

57.17%

Operating Margin

10.01%

Net Income Margin

3.11%

Return on Equity

6.89%

Return on Capital

10.23%

Return on Assets

2.71%

Earnings Yield

3.11%

Dividend Yield

3.25%

Payout Ratio

1.03%

Stock Overview

Market Cap

$1.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

957.11M

Volume

5.00K

Avg. Volume

9.30K

Financials (TTM)

Gross Profit

£949.53M

Operating Income

£132.88M

EBITDA

£255.84M

Operating Cash Flow

£345.21M

Capital Expenditure

-£18.64M

Free Cash Flow

£326.66M

Cash & ST Invst.

£180.76M

Total Debt

£392.40M

Dr. Martens Plc Performance Analysis

Dr. Martens Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31GBP 1,204,113,730-2.9%
20242024-03-31GBP 1,101,655,398-8.5%
20252025-03-31GBP 1,004,717,327-8.8%
20262026-03-31GBP 1,025,026,8692.0%
Dr. Martens Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30-32.6%
Q42025-03-3042.6%
Q22025-09-30-30.5%
Q42026-03-3138.0%
Dr. Martens Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31GBP 0.16-37.2%
20242024-03-31GBP 0.09-43.1%
20252025-03-31GBP 0.01-93.3%
20262026-03-31GBP 0.03452.5%
Dr. Martens Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30-143.0%
Q42025-03-30253.6%
Q22025-09-30-130.8%
Q42026-03-31433.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

£444.03M

-7.7%

Gross Profit

£262.27M

-18.1%

Gross Margin

59.07%

N/A

Market Cap

$1.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$426.82K

N/A

Employees

2,377

N/A

Net Income

£33.89M

-32.5%

EBITDA

£107.67M

+21.1%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

£180.76M

+62.7%

Total Debt

£392.40M

-16.3%

Accounts Receivable

£69.18M

+27.4%

Inventory

£161.21M

-36.7%

Long Term Debt

£348.19M

-17.4%

Short Term Debt

£46.20M

-16.6%

Return on Assets

2.71%

N/A

Return on Invested Capital

10.68%

N/A

Free Cash Flow

£136.95M

-26.0%

Operating Cash Flow

£141.96M

-25.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CVSGFCVS Group plc
$16.53+0.00%
MGLUYMagazine Luiza S.A.
$3.90-2.26%
TNIEFtonies SE
$13.57+4.32%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
AMIXAutonomix Medical
$19.04+4.22%
SPCXSpace Exploration Technologies
$125.52+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$8.08+0.03%

Questions About DOCMF

What is the current price of Dr. Martens Plc?

Dr. Martens Plc is trading at $1.06 per share.

What is the 52-week range for Dr. Martens Plc?

Over the past 52 weeks, Dr. Martens Plc has traded between $0.81 and $1.36.

How much debt does Dr. Martens Plc have?

As of the most recent reporting period, Dr. Martens Plc reported total debt of £516.14M.

How much cash does Dr. Martens Plc have on hand?

Dr. Martens Plc reported £237.76M in cash and cash equivalents in its most recent financial results.

What is Dr. Martens Plc’s dividend yield?

Dr. Martens Plc currently has a dividend yield of 3.25%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services